Peng M - Search Results

1

Immunogenomic profiles and therapeutic options of the pan-programmed cell death-related lncRNA signature for patients with bladder cancer.

Yang J, Zhang L, Zhu B, Wu H, Peng M. Yang J, et al. Among authors: peng m. Sci Rep. 2024 Aug 9;14(1):18500. doi: 10.1038/s41598-024-68859-w. Sci Rep. 2024. PMID: 39122807 Free PMC article.

2

Integrated bioinformatic analysis identified a novel prognostic pan-programmed cell death signature for bladder cancer.

Zhang L, Peng M. Zhang L, et al. Among authors: peng m. Front Immunol. 2022 Nov 23;13:1030097. doi: 10.3389/fimmu.2022.1030097. eCollection 2022. Front Immunol. 2022. PMID: 36505448 Free PMC article.

3

A novel prognostic biomarker LCP2 correlates with metastatic melanoma-infiltrating CD8⁺ T cells.

Wang Z, Peng M. Wang Z, et al. Among authors: peng m. Sci Rep. 2021 Apr 28;11(1):9164. doi: 10.1038/s41598-021-88676-9. Sci Rep. 2021. PMID: 33911146 Free PMC article.

4

Immune landscape of distinct subtypes in urothelial carcinoma based on immune gene profile.

Peng M. Peng M. Front Immunol. 2022 Aug 8;13:970885. doi: 10.3389/fimmu.2022.970885. eCollection 2022. Front Immunol. 2022. PMID: 36003383 Free PMC article.

5

Comparison of bipolar plasmakinetic resection of prostate versus photoselective vaporization of prostate by a three year retrospective observational study.

Cheng X, Qin C, Xu P, Li Y, Peng M, Wu S, Ren D, Zhou L, Wang Y. Cheng X, et al. Among authors: peng m. Sci Rep. 2021 May 12;11(1):10142. doi: 10.1038/s41598-021-89623-4. Sci Rep. 2021. PMID: 33980942 Free PMC article.

6

Integrated Analysis of a Competing Endogenous RNA Network Reveals a Prognostic lncRNA Signature in Bladder Cancer.

Peng M, Cheng X, Xiong W, Yi L, Wang Y. Peng M, et al. Front Oncol. 2021 Aug 2;11:684242. doi: 10.3389/fonc.2021.684242. eCollection 2021. Front Oncol. 2021. PMID: 34408977 Free PMC article.

7

The YTHDC1/GLUT3/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression.

Yan B, Li X, Peng M, Zuo Y, Wang Y, Liu P, Ren W, Jin X. Yan B, et al. Among authors: peng m. Exp Mol Med. 2023 Jun;55(6):1145-1158. doi: 10.1038/s12276-023-00997-z. Epub 2023 Jun 1. Exp Mol Med. 2023. PMID: 37258572 Free PMC article.

8

Gene set based systematic analysis of prostate cancer and its subtypes.

Ye S, Wang H, He K, Shen H, Peng M, Nian Y, Cui R, Yi L. Ye S, et al. Among authors: peng m. Future Oncol. 2020 Jan;16(2):4381-4393. doi: 10.2217/fon-2019-0459. Epub 2019 Dec 9. Future Oncol. 2020. PMID: 31814446

9

UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer.

Wang Z, Wang Y, Peng M, Yi L. Wang Z, et al. Among authors: peng m. Front Oncol. 2020 Jan 15;9:1517. doi: 10.3389/fonc.2019.01517. eCollection 2019. Front Oncol. 2020. PMID: 32010618 Free PMC article.

10

YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway.

Li W, Ye K, Li X, Liu X, Peng M, Chen F, Xiong W, Wang Y, Zhu L. Li W, et al. Among authors: peng m. J Exp Clin Cancer Res. 2022 Aug 17;41(1):250. doi: 10.1186/s13046-022-02460-9. J Exp Clin Cancer Res. 2022. PMID: 35974388 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,803 results

Search Page

Filters